Recent studies have revealed SOCS3 overexpression can inhibit cell proliferation and anchorage-independent growth in breast cancer cells [10], whereas down-regulation of SOCS3 reflects a poor prognosis in gastric cancer and hepatocellular carcinoma [11, 12]. This evidence concerns the gene SOCS3 and gastric cancer.